These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 12415808)

  • 1. New anti-tubulin agents.
    Felip E
    Suppl Tumori; 2002; 1(4):S17-8. PubMed ID: 12415808
    [No Abstract]   [Full Text] [Related]  

  • 2. The development of docetaxel (Taxotere) in non-small cell lung cancer.
    Kris MG; Miller VA; Ng KK; Grant SC
    Semin Oncol; 1997 Aug; 24(4 Suppl 14):S14-1-S14-4. PubMed ID: 9335515
    [No Abstract]   [Full Text] [Related]  

  • 3. Role of taxanes in lung-cancer chemotherapy.
    Schiller JH
    Cancer Invest; 1998; 16(7):471-7. PubMed ID: 9774954
    [No Abstract]   [Full Text] [Related]  

  • 4. Novel taxanes/epothilones.
    Dy G
    J Thorac Oncol; 2010 Dec; 5(12 Suppl 6):S490-1. PubMed ID: 21102252
    [No Abstract]   [Full Text] [Related]  

  • 5. Docetaxel as second-line chemotherapy for non-small-cell lung cancer.
    Roila F; Del Favero A; Ballatori E
    J Clin Oncol; 2000 Nov; 18(21):3738-9. PubMed ID: 11054450
    [No Abstract]   [Full Text] [Related]  

  • 6. Docetaxel: current status and future prospects.
    Eisenhauer E
    J Clin Oncol; 1995 Dec; 13(12):2865-8. PubMed ID: 8523048
    [No Abstract]   [Full Text] [Related]  

  • 7. Docetaxel (Taxotere) in the treatment of non-small cell lung cancer.
    Kris MG; Millward M
    Semin Oncol; 1999 Jun; 26(3 Suppl 10):1-2. PubMed ID: 10437742
    [No Abstract]   [Full Text] [Related]  

  • 8. Docetaxel (Taxotere) in the treatment of non-small cell lung cancer: an international update.
    Kris MG; Manegold C
    Semin Oncol; 2001 Feb; 28(1 Suppl 2):1-3. PubMed ID: 11284618
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Docetaxel (Taxotere) in the treatment of non-small cell lung cancer: recent results and future developments.
    Rosell R
    Semin Oncol; 1999 Jun; 26(3 Suppl 11):1-3. PubMed ID: 10458202
    [No Abstract]   [Full Text] [Related]  

  • 10. Expanding horizons: an update on the use of docetaxel in non-small cell lung, ovarian, and breast cancers.
    Hortobagyi GN; Kris MG
    Semin Oncol; 2002 Jun; 29(3 Suppl 12):1-3. PubMed ID: 12170444
    [No Abstract]   [Full Text] [Related]  

  • 11. Novel taxane formulations and microtubule-binding agents in non-small-cell lung cancer.
    Edelman MJ
    Clin Lung Cancer; 2009 Mar; 10 Suppl 1():S30-4. PubMed ID: 19362944
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Docetaxel (Taxotere) in the treatment of cancer.
    Burris HA
    Semin Oncol; 2000 Apr; 27(2 Suppl 3):1-2. PubMed ID: 10810931
    [No Abstract]   [Full Text] [Related]  

  • 13. [Taxotere in various solid tumors].
    Orel NF
    Vopr Onkol; 1998; 44(5):639-44. PubMed ID: 9925501
    [No Abstract]   [Full Text] [Related]  

  • 14. [Recent results of anticancer drugs acting on microtubules--navelbine, taxol and taxotere for the treatment of lung cancer].
    Kawahara M; Furuse K
    Gan To Kagaku Ryoho; 1992 Nov; 19(13):2150-6. PubMed ID: 1359840
    [No Abstract]   [Full Text] [Related]  

  • 15. Docetaxel as neo-adjuvant therapy for radically treatable stage III non-small cell lung cancer: early results of an international phase III study.
    Mattson K; Abratt R; Ten GV; Krofta K; Tonelli D; Avril I
    Lung Cancer; 2001 Dec; 34 Suppl 4():S21-3. PubMed ID: 11742698
    [No Abstract]   [Full Text] [Related]  

  • 16. Epothilones in development for non--small-cell lung cancer: novel anti-tubulin agents with the potential to overcome taxane resistance.
    Edelman MJ; Shvartsbeyn M
    Clin Lung Cancer; 2012 May; 13(3):171-80. PubMed ID: 22133291
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inflammation of seborrheic keratoses due to docetaxel treatment.
    Chu CY; Yang CH; Chiu HC
    Acta Derm Venereol; 2001; 81(4):316-7. PubMed ID: 11720193
    [No Abstract]   [Full Text] [Related]  

  • 18. The taxanes: an update.
    Crown J; O'Leary M
    Lancet; 2000 Apr; 355(9210):1176-8. PubMed ID: 10791395
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reversible hepatic coma possibly induced by docetaxel treatment.
    Chen YM; Tsai CM; Perng RP
    Lung Cancer; 2001; 31(2-3):347-8. PubMed ID: 11305259
    [No Abstract]   [Full Text] [Related]  

  • 20. The taxoids: paclitaxel and docetaxel.
    Gelmon K
    Lancet; 1994 Nov; 344(8932):1267-72. PubMed ID: 7967989
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.